Answers are grounded in this paper and cite their sources.
Genome-wide association analysis reveals key immune genes in rheumatoid arthritis, suggesting new therapeutic targets.
Background Rheumatoid arthritis ( RA ) is a complex autoimmune disease influenced by genetic and immune dysregulation. The causal roles of specific immune‐related genes in RA pathogenesis remain incompletely understood. Methods We conducted a large‐scale genome‐wide association study ( GWAS ) meta‐analysis across three RA cohorts to identify genome‐wide significant risk loci. Causal genes and proteins were prioritized by integrating these results with cis‐ eQTL and pQTL datasets using two‐sample Mendelian randomization ( MR ) and summary‐data‐based MR ( SMR ). Cell‐type‐specific expression was assessed using single‐cell RNA sequencing ( scRNA ‐seq), and gene expression in RA synovial tissue was validated via bulk RNA ‐seq. Results We identified 29 independent RA ‐associated loci, including 7 novel associations. Integrated MR and SMR analyses classified ERAP2 as a high‐confidence causal gene, while SWAP70 and LTBR were deemed moderate‐confidence causal genes. SWAP70 showed a protective association, whereas ERAP2 and LTBR were positively associated with RA risk. Single‐cell transcriptomic analysis revealed cell‐type‐specific enrichment, with SWAP70 prevalent in B cells and LTBR in dendritic cells. Bulk RNA ‐seq confirmed the upregulation of SWAP70 , RASGRP1 , and RHOH in RA patients. Conclusion Our integrative multi‐omics framework reveals immune regulatory genes with potential causal roles in RA pathogenesis, highlighting ERAP2 , SWAP70 , LTBR , and other candidates as promising therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: